All In Biotech

Drug Trial Radar · NCT07138196

A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease

A Phase 1b, Open-label Dose Escalation Study to Evaluate the Safety, Pharmacodynamic, Pharmacokinetic and Preliminary Efficacy of Q702 in Subjects With Relapsed or Refractory Active Chronic Graft-versus-Host Disease (cGVHD)

Last checked: Nov 19, 2026Latest source record: Dec 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

18

Planned (sponsor's estimate)

Start

Dec 23, 2025

Primary completion

Oct 23, 2029

Study completion Oct 31, 2029

Sponsor

Lead sponsor
Qurient Co., Ltd.Industry
Sponsor type
Industry
First posted
Aug 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Open-label, dose escalation study to evaluate safety, tolerability pharmacokinetic and pharmacodynamic activity, and efficacy of Adrixetinib (Q702) in subjects with relapsed or refractory active chronic graft-versus-host disease (cGVHD).

Conditions

  • Chronic Graft-Versus-Host Disease

Interventions

  • AdrixetinibDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Dose-Limiting Toxicities (DLTs)Time frame: Cycle 1 (28 Days)
  2. Number of Participants with Adverse Event(s) (AEs) and Serious Adverse Event(s) (SAEs)Time frame: Cycle 1 (28 Days)

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital Clinic de Barcelona

    Barcelona, Spain · Recruiting

  • Hospital General Universitario Gregorio Maranon

    Madrid, Spain · Recruiting

  • Hospital Universitario Puerta de Hierro Majadahonda

    Majadahonda, Spain · Recruiting

  • Hospital Universitario Virgen de la Arrixaca

    Murcia, Spain · Recruiting

  • Clinica Universidad de Navarra

    Pamplona, Spain · Recruiting

  • Hospital Universitario Marques de Valdecilla

    Santander, Spain · Recruiting

  • Hospital Universitario Virgen del Rocio

    Seville, Spain · Recruiting

  • Instituto de Investigacion Sanitaria

    Valencia, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.